Kidney Disease Stem Cell Treatment: 300 Million MSC IV
Kidney disease stem cell treatment at Dream Body Clinic is a regenerative protocol that delivers a 300 million mesenchymal stem cell (MSC) intravenous infusion to support reduced renal inflammation, tissue repair signaling, and improved kidney function. The all-inclusive package is $11,500 USD and includes bloodwork, NAD+ and high-dose vitamin C IV, and physician review.
The cells are allogeneic MSCs derived from Wharton’s jelly and placenta, expanded on site in the clinic’s ISO-rated lab. Patients plan a minimum four-day stay in the BucerÃas / Puerto Vallarta area. Treatment is administered after laboratory clearance. Results vary, and the clinic does not treat patients with cancer in the past five years.
Our MSCs are derived from Wharton Jelly & placenta from live, healthy births in our COFEPRIS certified and ISO rated lab on site.
A free consultation is available to review candidacy and current availability. Call (888) 704-3977 or email info@dreambodyclinic.net.
Kidney Disease Stem Cell Treatment
We require patients to be in town for at least 4 days. Below is what a typical schedule looks like, but exact details are subject to change depending on availability and schedule
What’s included in your protocol
Typical Treatment Schedule
Watch & Learn
The Kidney Disease Stem Cell Treatment at Dream Body Clinic
How do Mesenchymal Stem Cells work for Kidney Disease?
Acute Kidney Injury (AKI)
Chronic Kidney Disease (CKD)
Stages 1, 2 or 3 Kidney Failure
Diabetic Nephropathy
Alport syndrome
Lupus Nephritis
Nephrotic Syndrome
Glomerulonephritis
Interstitial Nephritis
Autosomal dominant polycystic kidney disease (ADPKD)
How do mesenchymal stem cells benefit mesangial cells in kidney disease?
How do mesenchymal stem cells benefit proximal tubular epithelial cells in kidney disease?
How do mesenchymal stem cells benefit endothelial cells in kidney disease?
How long do the Kidney Disease Stem Cell Treatment Results Last?
How to get the Kidney Disease Stem Cell Treatment
Side Effects or Risks
- 1 in 100 people will experience a slight fever and/or headache for a few hours after treatment or the next day. We have found that 500mg of Tylenol easily resolves this issue.
- Any treatment involving an injection such as an IV runs a risk of infection. We have never had a patient experience an infection due to our sterility protocols,.
- We do not treat patients that have had cancer within the past 5 years. There is still no conclusive evidence linking stem cells to make cancer worse, but we prefer to stay on the side of safety until more information is available.
- As with any medical treatment there is no guarantee of results, but our outcomes have been great for the vast majority of patients.
- In all patients who receive an intravenous treatment of any sort, there is a risk of releasing a thrombus or plaque from the veins, even more so if the patient has mainly high cholesterol levels. If a thrombosis or phlebitis were to occur, it would occur immediately. This has not been an issue with our patients, but any sort of IV has this risk. This is why we do bloodwork for all patients to make sure that treatment is as safe as possible for them.Â
The only side effects that have been documented are the following:
Our lab has over 8 years of experience cultivating mesenchymal stem cells with perfect safety and efficacy. See Stem Cell Certification by Clicking Here
Kidney Disease Stem Cell Studies
Selected peer-reviewed publications supporting this treatment.
Call (888) 704-3977
For a Free Consultation
Or email us at info@dreambodyclinic.net
Reviewed by the treating physician
Dr. Arick Francisco Barba Lopez
Head Physician
Dream Body Clinic, Bucerias, Mexico
- Graduate, Universidad Autónoma de Guadalajara
- Graduate certificate in regenerative medicine
- About 10 years administering mesenchymal stem cell therapies
- Honoris Causa, UNCEMA, 2021
- Reviews this page for protocol, dose, and candidacy accuracy
Content last reviewed September 26, 2026 · Next scheduled review March 2027
This page describes a clinic protocol, not an FDA-approved U.S. indication.
